Last update 07 Nov 2024

Mecbotamab vedotin

Overview

Basic Info

Drug Type
Probody drug conjugates
Synonyms
CAB-Axl antibody-drug conjugates, CAB-AXL-ADC, BA 3011
+ [1]
Mechanism
AXL inhibitors(AXL receptor tyrosine kinase inhibitors), Tubulin inhibitors
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC39H67N5O7
InChIKeyDASWEROEPLKSEI-UIJRFTGLSA-N
CAS Registry474645-27-7
View All Structures (2)
Boost your research with our XDC technology data.
Boost your research with our XDC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ovarian CancerPhase 2
US
12 Oct 2021
Platinum-Resistant Ovarian CarcinomaPhase 2
US
12 Oct 2021
Platinum-Resistant Ovarian CarcinomaPhase 2
CA
12 Oct 2021
metastatic non-small cell lung cancerPhase 2
US
17 Mar 2021
metastatic non-small cell lung cancerPhase 2
GR
17 Mar 2021
metastatic non-small cell lung cancerPhase 2
HK
17 Mar 2021
metastatic non-small cell lung cancerPhase 2
IT
17 Mar 2021
metastatic non-small cell lung cancerPhase 2
PL
17 Mar 2021
metastatic non-small cell lung cancerPhase 2
ES
17 Mar 2021
metastatic non-small cell lung cancerPhase 2
TW
17 Mar 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
113
vrahpzxbts(iwdnhajgeu) = The most common TEAEs of special interest among monotherapy pts were peripheral neuropathy (32.2%), neutropenia (25.3%), and abnormal liver function tests (20.7%). cpszpwekzl (lmhzphlcrv )
Positive
14 Mar 2024
BA3011 monotherapy and BA3011 + nivolumab
Phase 2
40
BA3011
wbvmggudoc(kyeiheeuof) = lyllwklxnr hqfvgpwgei (nvgjxiuebc )
Positive
05 Dec 2023
Phase 2
17
(先前 PD-1/L1、EGFR 或 ALK 抑制剂治疗失败的 AXL 阳性 NSCLC 患者)
llofpfikwu(vcnygglmbj) = zjveaqeddl hvltksxfgf (wlookibhlt )
Positive
12 Sep 2022
(多形性肉瘤)
cfmgczcbhv(sibfkxelwg) = iojtiskhtc pfubmehftr (ghqxvhgdgk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free